89 related articles for article (PubMed ID: 18838483)
21. Production of prostacyclin and prostaglandin E2 in resting and IL-1beta-stimulated A549, HUVEC and hybrid EA.HY 926 cells.
Olszanecki R; Gebska A; Korbut R
J Physiol Pharmacol; 2006 Dec; 57(4):649-60. PubMed ID: 17229988
[TBL] [Abstract][Full Text] [Related]
22. The induction of cyclooxygenase-2 in IL-1beta-treated endothelial cells is inhibited by prostaglandin E2 through cAMP.
Akarasereenont P; Techatrisak K; Chotewuttakorn S; Thaworn A
Mediators Inflamm; 1999; 8(6):287-94. PubMed ID: 10815617
[TBL] [Abstract][Full Text] [Related]
23. Role of cyclo-oxygenase-2 induction in interleukin-1beta induced attenuation of cultured human airway smooth muscle cell cyclic AMP generation in response to isoprenaline.
Pang L; Holland E; Knox AJ
Br J Pharmacol; 1998 Nov; 125(6):1320-8. PubMed ID: 9863663
[TBL] [Abstract][Full Text] [Related]
24. Cyclooxygenase isozymes are expressed in human myeloma cells but not involved in anti-proliferative effect of cyclooxygenase inhibitors.
Ding J; Tsuboi K; Hoshikawa H; Goto R; Mori N; Katsukawa M; Hiraki E; Yamamoto S; Abe M; Ueda N
Mol Carcinog; 2006 Apr; 45(4):250-9. PubMed ID: 16385588
[TBL] [Abstract][Full Text] [Related]
25. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis.
Erickson BA; Longo WE; Panesar N; Mazuski JE; Kaminski DL
J Surg Res; 1999 Jan; 81(1):101-7. PubMed ID: 9889067
[TBL] [Abstract][Full Text] [Related]
26. Cytoskeletal architecture regulates cyclooxygenase-2 in human endothelial cells: autocrine modulation by prostacyclin.
Eligini S; Songia P; Cavalca V; Crisci M; Tremoli E; Colli S
J Cell Physiol; 2012 Dec; 227(12):3847-56. PubMed ID: 22495438
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of COX-1/COX-2 selectivity and potency of a new class of COX-2 inhibitors.
Gierse J; Nickols M; Leahy K; Warner J; Zhang Y; Cortes-Burgos L; Carter J; Seibert K; Masferrer J
Eur J Pharmacol; 2008 Jun; 588(1):93-8. PubMed ID: 18457826
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-1beta, transforming growth factor-beta1, and bradykinin attenuate cyclic AMP production by human pulmonary artery smooth muscle cells in response to prostacyclin analogues and prostaglandin E2 by cyclooxygenase-2 induction and downregulation of adenylyl cyclase isoforms 1, 2, and 4.
El-Haroun H; Bradbury D; Clayton A; Knox AJ
Circ Res; 2004 Feb; 94(3):353-61. PubMed ID: 14670842
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of prostaglandin E2 synthesis by SC-560 is independent of cyclooxygenase 1 inhibition.
Brenneis C; Maier TJ; Schmidt R; Hofacker A; Zulauf L; Jakobsson PJ; Scholich K; Geisslinger G
FASEB J; 2006 Jul; 20(9):1352-60. PubMed ID: 16816110
[TBL] [Abstract][Full Text] [Related]
30. Honokiol up-regulates prostacyclin synthease protein expression and inhibits endothelial cell apoptosis.
Zhang X; Chen S; Wang Y
Eur J Pharmacol; 2007 Jan; 554(1):1-7. PubMed ID: 17109844
[TBL] [Abstract][Full Text] [Related]
31. IL-1beta stimulates the expression of prostaglandin receptor EP4 in human chondrocytes by increasing production of prostaglandin E2.
Watanabe Y; Namba A; Honda K; Aida Y; Matsumura H; Shimizu O; Suzuki N; Tanabe N; Maeno M
Connect Tissue Res; 2009; 50(3):186-93. PubMed ID: 19444759
[TBL] [Abstract][Full Text] [Related]
32. Anti-inflammatory and vascularprotective properties of 8-prenylapigenin.
Paoletti T; Fallarini S; Gugliesi F; Minassi A; Appendino G; Lombardi G
Eur J Pharmacol; 2009 Oct; 620(1-3):120-30. PubMed ID: 19686724
[TBL] [Abstract][Full Text] [Related]
33. Engagement of CD44 modulates cyclooxygenase induction, VEGF generation, and proliferation in human vascular endothelial cells.
Murphy JF; Lennon F; Steele C; Kelleher D; Fitzgerald D; Long AC
FASEB J; 2005 Mar; 19(3):446-8. PubMed ID: 15640281
[TBL] [Abstract][Full Text] [Related]
34. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis.
Belton OA; Duffy A; Toomey S; Fitzgerald DJ
Circulation; 2003 Dec; 108(24):3017-23. PubMed ID: 14638539
[TBL] [Abstract][Full Text] [Related]
35. Human pharmacology of naproxen sodium.
Capone ML; Tacconelli S; Sciulli MG; Anzellotti P; Di Francesco L; Merciaro G; Di Gregorio P; Patrignani P
J Pharmacol Exp Ther; 2007 Aug; 322(2):453-60. PubMed ID: 17473175
[TBL] [Abstract][Full Text] [Related]
36. Cyclooxygenase-2-derived endogenous prostacyclin enhances mouse embryo hatching.
Huang JC; Wun WS; Goldsby JS; Matijevic-Aleksic N; Wu KK
Hum Reprod; 2004 Dec; 19(12):2900-6. PubMed ID: 15489241
[TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase-2 mediates hydrogen peroxide-induced wound repair in human endothelial cells.
Eligini S; Arenaz I; Barbieri SS; Faleri ML; Crisci M; Tremoli E; Colli S
Free Radic Biol Med; 2009 May; 46(10):1428-36. PubMed ID: 19269318
[TBL] [Abstract][Full Text] [Related]
38. COX-2 inhibitors selectively block prostacyclin synthesis in endotoxin-exposed vascular smooth muscle cells.
Schildknecht S; Bachschmid M; Baumann A; Ullrich V
FASEB J; 2004 Apr; 18(6):757-9. PubMed ID: 14977876
[TBL] [Abstract][Full Text] [Related]
39. Effects of cyclooxygenase inhibition on canine coronary artery blood flow and thrombosis.
Hong TT; Huang J; Barrett TD; Lucchesi BR
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H145-55. PubMed ID: 17921331
[TBL] [Abstract][Full Text] [Related]
40. Regulation of cerebral microvascular endothelial cell cyclooxygenase-2 message and activity by blood derived vasoactive agents.
Yakubu MA; Leffler CW
Brain Res Bull; 2005 Dec; 68(3):150-6. PubMed ID: 16325014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
